Skip to main content
Top
Published in: Diabetologia 8/2008

01-08-2008 | Article

A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit

Authors: M. E. Jørgensen, K. Borch-Johnsen, P. Bjerregaard

Published in: Diabetologia | Issue 8/2008

Login to get access

Abstract

Aims/hypothesis

Some evidence supports the hypothesis that persistent organic pollutants (POPs) may increase the risk of type 2 diabetes. The Inuit population in Greenland, which is highly exposed to POPs due to a high intake of marine mammals, has experienced a rapid increase in diabetes prevalence over the last 30 years. Thus the aim was to study the association between POPs and glucose intolerance and markers of insulin resistance and insulin secretion using a population-based design.

Methods

From 1999 to 2002 the Greenland population study was carried out among adult Inuit living in Greenland. The examination included a 75 g OGTT, anthropometric measurements, a structured interview, and blood tests. Plasma glucose and serum insulin were analysed, and three defined subclasses of POPs were analysed in a subgroup. Associations were adjusted for age, sex, waist circumference, Inuit heritage, cigarette smoking, alcohol consumption and educational level.

Results

Data on POPs were available on 692 individuals, 305 men (mean age 50 years) and 387 women (mean age 49 years). The prevalence of diabetes was 10.3%, and 10.5% had impaired glucose tolerance. The concentrations of several POPs were exceptionally high. While no associations were found between POPs and stages of glucose intolerance or markers of insulin resistance, POPs were significantly inversely associated with stimulated insulin concentrations and homeostasis model assessment of beta cell function.

Conclusions/interpretation

The study indicates that POPs may affect insulin secretion rather than being involved in the pathogenesis of insulin resistance. No association was seen between POPs and glucose intolerance or markers of insulin resistance.
Literature
1.
go back to reference Remillard RB, Bunce NJ (2002) Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 110:853–858PubMed Remillard RB, Bunce NJ (2002) Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 110:853–858PubMed
2.
go back to reference Steenland K, Calvert G, Ketchum N, Michalek J (2001) Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data. Occup Environ Med 58:641–648PubMedCrossRef Steenland K, Calvert G, Ketchum N, Michalek J (2001) Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data. Occup Environ Med 58:641–648PubMedCrossRef
3.
go back to reference Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC (1998) The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect 106(Suppl 2):625–633PubMedCrossRef Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC (1998) The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect 106(Suppl 2):625–633PubMedCrossRef
4.
go back to reference Vena J, Boffetta P, Becher H et al (1998) Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106(Suppl 2):645–653PubMedCrossRef Vena J, Boffetta P, Becher H et al (1998) Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106(Suppl 2):645–653PubMedCrossRef
5.
go back to reference Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI (1999) Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 91:779–786PubMedCrossRef Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI (1999) Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 91:779–786PubMedCrossRef
6.
go back to reference Longnecker MP, Michalek JE (2000) Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 11:44–48PubMedCrossRef Longnecker MP, Michalek JE (2000) Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 11:44–48PubMedCrossRef
7.
go back to reference Henriksen GL, Ketchum NS, Michalek JE, Swaby JA (1997) Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252–258PubMedCrossRef Henriksen GL, Ketchum NS, Michalek JE, Swaby JA (1997) Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252–258PubMedCrossRef
8.
go back to reference Rylander L, Rignell-Hydbom A, Hagmar L (2005) A cross-sectional study of the association between persistent organochlorine pollutants and diabetes. Environ Health 4:28PubMedCrossRef Rylander L, Rignell-Hydbom A, Hagmar L (2005) A cross-sectional study of the association between persistent organochlorine pollutants and diabetes. Environ Health 4:28PubMedCrossRef
9.
go back to reference Lee DH, Lee IK, Song KE et al (2006) A strong dose–response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey. Diabetes Care 29:1638–1644PubMedCrossRef Lee DH, Lee IK, Song KE et al (2006) A strong dose–response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey. Diabetes Care 29:1638–1644PubMedCrossRef
10.
go back to reference Fierens S, Mairesse H, Heilier JF et al (2003) Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8:529–534PubMedCrossRef Fierens S, Mairesse H, Heilier JF et al (2003) Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8:529–534PubMedCrossRef
11.
go back to reference Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W (2006) Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17:352–359PubMedCrossRef Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W (2006) Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17:352–359PubMedCrossRef
12.
go back to reference Bjerregaard P, Dewailly E, Ayotte P, Pars T, Ferron L, Mulvad G (2001) Exposure of Inuit in Greenland to organochlorines through the marine diet. J Toxicol Environ Health A 62:69–81PubMedCrossRef Bjerregaard P, Dewailly E, Ayotte P, Pars T, Ferron L, Mulvad G (2001) Exposure of Inuit in Greenland to organochlorines through the marine diet. J Toxicol Environ Health A 62:69–81PubMedCrossRef
13.
go back to reference AMAP (2004) AMAP assessment 2002: persistent organic pollutants in the Arctic. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway AMAP (2004) AMAP assessment 2002: persistent organic pollutants in the Arctic. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway
14.
go back to reference Jørgensen ME, Bjerregaard P, Borch-Johnsen K (2002) Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care 25:1766–1771PubMedCrossRef Jørgensen ME, Bjerregaard P, Borch-Johnsen K (2002) Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care 25:1766–1771PubMedCrossRef
15.
go back to reference Bjerregaard P, Curtis T, Borch-Johnsen K et al (2003) Inuit Health in Greenland: A population survey of life style and disease in Greenland and among Inuit living in Denmark. Int J Circumpolar Health 62(Suppl 1):1–79 Bjerregaard P, Curtis T, Borch-Johnsen K et al (2003) Inuit Health in Greenland: A population survey of life style and disease in Greenland and among Inuit living in Denmark. Int J Circumpolar Health 62(Suppl 1):1–79
16.
go back to reference WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. WHO/NCD/NCS/99.2. WHO, Geneva WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. WHO/NCD/NCS/99.2. WHO, Geneva
17.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
18.
go back to reference Phillips DL, Pirkle JL, Burse VW, Bernet JT, Henderson LO, Needham LL (1989) Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18:495–500PubMedCrossRef Phillips DL, Pirkle JL, Burse VW, Bernet JT, Henderson LO, Needham LL (1989) Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18:495–500PubMedCrossRef
19.
go back to reference Longnecker MP (2006) Pharmacokinetic variability and the miracle of modern analytical chemistry. Epidemiology 17:350–351PubMedCrossRef Longnecker MP (2006) Pharmacokinetic variability and the miracle of modern analytical chemistry. Epidemiology 17:350–351PubMedCrossRef
20.
go back to reference Schisterman EF, Whitcomb BW, Buck-Louis GM, Louis TA (2005) Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 113:853–857PubMedCrossRef Schisterman EF, Whitcomb BW, Buck-Louis GM, Louis TA (2005) Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 113:853–857PubMedCrossRef
21.
go back to reference Fujiyoshi PT, Michalek JE, Matsumura F (2006) Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect 114:1677–1683PubMed Fujiyoshi PT, Michalek JE, Matsumura F (2006) Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect 114:1677–1683PubMed
22.
go back to reference Long M, Andersen BS, Lindh CH et al (2006) Dioxin-like activities in serum across European and Inuit populations. Environ Health 5:14PubMedCrossRef Long M, Andersen BS, Lindh CH et al (2006) Dioxin-like activities in serum across European and Inuit populations. Environ Health 5:14PubMedCrossRef
23.
go back to reference Salmerón J, Hu FB, Manson JE et al (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73:1019–1026PubMed Salmerón J, Hu FB, Manson JE et al (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73:1019–1026PubMed
24.
go back to reference Storlien LH, Baur LA, Kriketos AD et al (1996) Dietary fats and insulin action. Diabetologia 39:621–631PubMedCrossRef Storlien LH, Baur LA, Kriketos AD et al (1996) Dietary fats and insulin action. Diabetologia 39:621–631PubMedCrossRef
25.
go back to reference Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Collaborative Perinatal Project (CPP) (2001) Polychlorinated biphenyl serum levels in pregnant subjects with diabetes. Diabetes Care 24:1099–1101CrossRef Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Collaborative Perinatal Project (CPP) (2001) Polychlorinated biphenyl serum levels in pregnant subjects with diabetes. Diabetes Care 24:1099–1101CrossRef
26.
go back to reference Langer P, Tajtáková M, Guretzki HJ et al (2002) High prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in employees at a polychlorinated biphenyl production factory. Arch Environ Health 57:412–415PubMedCrossRef Langer P, Tajtáková M, Guretzki HJ et al (2002) High prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in employees at a polychlorinated biphenyl production factory. Arch Environ Health 57:412–415PubMedCrossRef
27.
go back to reference Fischer LJ, Wagner MA, Madhukar BV (1999) Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol 159:194–203PubMedCrossRef Fischer LJ, Wagner MA, Madhukar BV (1999) Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol 159:194–203PubMedCrossRef
Metadata
Title
A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit
Authors
M. E. Jørgensen
K. Borch-Johnsen
P. Bjerregaard
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1066-0

Other articles of this Issue 8/2008

Diabetologia 8/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine